Gijung Jung

Eligibility for lecanemab and donanemab in Korea under Appropriate Use Recommendations

IF11.1

2025-12-150

OAAI

韩国根据适当使用建议对lecanemab和donanemab的适用性评估

APOE4 modulates the association between DTI-ALPS index and Alzheimer's pathologies

IF11.1

2025-11-120

OAAI

APOE4调节了DTI-ALPS指数与阿尔茨海默病病理学之间的关联。

Alzheimer's & Dementia

IF11.1

2025-10-280

OAAI

Performance on the Rey-Osterrieth complex figure test in non-demented middle-aged and elderly Koreans

Rey-osterrieth复杂图形测试在非痴呆的中老年人中的表现

Normative data for the CERAD verbal episodic memory tests in a sample of older illiterate Korean women

IF3.1

2025-04-010

PRE

CERAD语言情景记忆测试在样本为老年不识字韩国女性中的常模数据

JOURNAL OF ALZHEIMERS DISEASE REPORTS

IF2.8

2025-02-270

Daily fluid intake and brain amyloid deposition: A cohort study

The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology

IF3.1

2025-02-211

ANNALS OF NEUROLOGY

IF7.7

2025-02-170

Locus coeruleus tau is linked to successive cortical tau accumulation

蓝斑tau与连续的皮质tau积累有关

Tau pathway-based gene analysis on PET identifies CLU and FYN in a Korean cohort

IF11.1

2024-12-060

PRE

基于Tau通路的PET基因分析在韩国队列中鉴定CLU和FYN

Genome-wide transcriptome analysis of Aβ deposition on PET in a Korean cohort

IF11.1

2024-12-030

韩国队列中a β 在PET上沉积的全基因组转录组分析

Moderation of Amyloid-β Deposition on the Effect of Cholinesterase Inhibitors on Cognition in Mild Cognitive Impairment

IF11.1

2024-11-080

OAAI

Moderation of thyroid hormones for the relationship between amyloid and tau pathology

IF3.1

2024-08-030

OAAI

调节甲状腺激素与淀粉样蛋白和tau病理之间的关系

Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities

IF7.6

2024-07-231

OAAI

脑淀粉样蛋白沉积与白质高信号纵向变化的关系

Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults

IF7.6

2024-03-071

OAAI

韩国老年人临床前阿尔茨海默病认知复合材料的开发

Body mass index and two-year change of in vivo Alzheimer's disease pathologies in cognitively normal older adults

IF3.1

2023-11-070

OAAI

Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults

IF7.6

2023-06-133

OAAI

Sex differences in the progression of glucose metabolism dysfunction in Alzheimer's disease

IF3.1

2023-05-021

OAAI

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2023-05-0113

OAAI

Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive decline

PSYCHIATRY AND CLINICAL NEUROSCIENCES

IF6.2

2023-01-044

Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology

高血压和脑 β-淀粉样蛋白对tau病理的协同作用